Albert D. Bolles's Insider Trades & SAST Disclosures
Albert D. Bolles's most recent trade in Sunopta, Inc. was a trade of 1,360 Common Shares done at an average price of $7.4 . Disclosure was reported to the exchange on Jan. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Albert D. Bolles.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sunopta, Inc. | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 7.38 per share. | 24 Jan 2025 | 1,360 | 204,110 (0%) | 0% | 7.4 | 10,037 | Common Shares |
| Sunopta, Inc. | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 6.02 per share. | 18 Oct 2024 | 1,629 | 202,750 (0%) | 0% | 6.0 | 9,807 | Common Shares |
| Arcadia Biosciences Inc | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 10,909 | 13,394 | - | - | Stock Option (Right to Buy) | |
| Sunopta, Inc. | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 5.23 per share. | 26 Jul 2024 | 1,912 | 201,121 (0%) | 0% | 5.2 | 10,000 | Common Shares |
| Sunopta, Inc. | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 20,072 | 20,072 | - | - | Restricted Stock Units | |
| Sunopta, Inc. | Albert D. Bolles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 15,283 | 199,209 (0%) | 0% | - | Common Shares | |
| Sunopta, Inc. | Albert D. Bolles | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 15,283 | 0 | - | - | Restricted Stock Units | |
| Sunopta, Inc. | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 5.96 per share. | 19 Apr 2024 | 1,337 | 183,926 (0%) | 0% | 6.0 | 7,969 | Common Shares |
| Sunopta, Inc. | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 6.03 per share. | 26 Jan 2024 | 1,679 | 182,589 (0%) | 0% | 6.0 | 10,124 | Common Shares |
| Arcadia Biosciences Inc | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 937 | 2,485 | - | - | Stock Option (Right to Buy) | |
| Arcadia Biosciences Inc | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 23,620 | 62,018 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2022 | 55,000 | 0 | - | - | Common Stock | |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 23 May 2022 | 55,000 | 100,152 (0%) | 0% | 9.5 | 519,750 | Common Stock |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.45 per share. | 23 May 2022 | 27,269 | 72,883 (0%) | 0% | 9.4 | 257,692 | Common Stock |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 91,763 | 91,763 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2021 | 8,237 | 8,237 | - | - | Incentive Stock Option (right to buy) | |
| Arcadia Biosciences Inc | Albert D. Bolles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 10,935 | 38,398 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.61 per share. | 14 Apr 2021 | 9,000 | 45,152 (0%) | 0% | 10.6 | 95,490 | Common Stock |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 10.98 per share. | 19 Jan 2021 | 10,000 | 36,152 (0%) | 0% | 11.0 | 109,800 | Common Stock |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 45,000 | 45,000 | - | - | Performance-Based Restricted Stock Units | |
| Arcadia Biosciences Inc | Albert D. Bolles | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 9,137 | 27,463 | - | - | Stock Option (right to buy) | |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 91,072 | 91,072 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | Albert D. Bolles | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2020 | 8,928 | 100,000 | - | - | Incentive Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges